Mankind pharma News: Mankind pharma Latest News, Mankind pharma Today news, Mankind pharma Breaking News

Nifty April expiry short covering rally rollover data India

April Rollover Alert: Why Sun Pharma, ONGC stand out but 1 sector is facing fresh ‘Short’ trap – Ambit reveals

Markets surged, but not on fresh buying: Ambit sees a short-covering rally as rollover data reveals selective bets in pharma,…

April 30, 2026 12:08 IST

stock market today india top movers april 7 wipro jubilant titagarh rail

Jio Financial to Waaree: Motilal Oswal rejigs model portfolio amid Middle East tension – 10 stocks in focus

Motilal Oswal is reshaping its FY26 strategy—betting on SBI, Jio Financial and domestic growth plays as crude risks and global…

April 7, 2026 10:09 IST

A financial chart showing the India VIX surging to 27, its highest since the Russia-Ukraine war, alongside a list of oversold stocks like HDFC Bank and ICICI Bank poised for a relief rally.

Monday Watchlist: Sun Pharma, HDFC Bank, ICICI, and 7 stocks to watch – VIX hits 2-year high

Monday watchlist, March 30: Track Sun Pharma, HDFC Bank and ICICI as market volatility surges; review key stock setups and…

March 30, 2026 05:30 IST

Mukul Agrawal’s Q3 2025 moves: A bold bet on these stocks. (Image Source: Canva)

Mukul Agarwal portfolio: Why he’s betting Rs 160 crore on these 2 contrasting stocks

Super investor and a Warren Buffett of India, Mukul Agarwal, has just added two new stocks to his portfolio sending…

January 12, 2026 05:30 IST

Divis Labs GLP drug manufacturing opportunity

5 ‘Buy’ recommendations by Jefferies in the pharma sector with at least 15% upside- Check full list

From generics to branded drugs, Jefferies’ latest pharma calls spotlight Alkem, Lupin, Sun Pharma, Torrent, and Zydus as India’s key…

Updated: December 12, 2025 14:16 IST

Buy these stocks in November and sell in December

Seasonality suggests November softness and December strength, yet select Pharma counters consistently outperform. Three stocks offering the favourable risk-reward from…

November 11, 2025 05:30 IST

brokerage consensus stocks 2026 India Q3 earnings analysis

Jefferies’ September shopping list: M&M, Sun Pharma & 3 more stocks set to rally – Do you own them?

Jefferies names M&M, TVS Motor, Jindal Stainless, Sun Pharma, and Mankind Pharma as top September buys—see why these stocks could…

September 15, 2025 11:15 IST

From Adani Enterprises, Maruti Suzuki, Coal India to Dabur India – Here are 10 stocks to watch

Stocks to watch today, August 01: GIFT Nifty indicates a lower start for domestic indices. Here are the top stocks…

August 1, 2025 06:46 IST

Trump tariff on India, pharma sector impact, Indian pharma exports

Trump tariff impact on Pharma: Breathing easy or trapped in crosshair ahead? Here’s how stocks are reacting

Trump’s new tariffs spark uncertainty for India’s pharma exports and stocks; check out how the sector is reacting and what…

July 31, 2025 10:59 IST

midday stock movers, MRF share price, PN Gadgil Jewellers Q1 results

Stocks making the biggest moves midday: HCL Tech, HUL, Vedanta, Phoenix Mills and more

Track midday stock movers like HCL Tech, Tata Steel, Mankind Pharma, and Vedanta; review key market catalysts and analyst insights…

July 9, 2025 14:05 IST

Empagliflozin, Empagliflozin generics, Empagliflozin Mankind Pharma, Rajeev Juneja, Glenmark Pharma, Alkem Labs, healthcare news, pharma news,

Mankind to sell its diabetes drug, Empagliflozin, for Rs 5, company expects 50% volume growth: Rajeev Juneja

On Wednesday, Glenmark and Alkem Labs launched the generic version as well as its Fixed Dose Combination (FDCs) of Empagliflozin…

March 12, 2025 13:56 IST

Boehringer Ingelheim, Boehringer Ingelheim India, Boehringer Ingelheim diabetes, Empagliflozin, Empagliflozin in India, patent loss, healthcare news pharma news,

Boehringer Ingelheim’s blockbuster diabetes drug goes off patent today—Will it lower treatment costs in India?

Empagliflozin is a SGLT-2 inhibitor and it has shown to significantly reduce the progression of kidney disease and heart failure.

March 11, 2025 10:51 IST

Mankind Pharma transfers OTC Business to subsidiary Mankind Consumer Products Private Limited

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

The integration of BSV is on track, with focus on mandate brands, improving productivity and adopting best practices to ensure…

January 23, 2025 19:39 IST

Q2FY25: Mankind Pharma’s profit jumps 29 percent to Rs 658.88 crore; Revenue up 13.6% to Rs 3,076.51 crore

During the quarter, we have launched 1 new product in US taking the total launched products to 42.

November 5, 2024 17:23 IST

Mankind Pharma acquires BSV to expand its portfolio in women’s health and fertility drug market

According to the company’s statement, Mankind Pharma may consider to retire, a portion of the debt through a potential equity…

October 24, 2024 11:34 IST

Mankind Pharma transfers OTC Business to subsidiary Mankind Consumer Products Private Limited

Mankind Pharma’s consumer products portfolio includes several trusted brands Manforce, HealthOK, Prega News, AcneStar, Unwanted and Gas-O-Fast across categories such…

October 1, 2024 13:57 IST